Cite
HARVARD Citation
Ceppi, F. et al. (n.d.). Safety and efficacy of intrathecal rituximab in children with B cell lymphoid CD20+ malignancies: An international retrospective study. American journal of hematology. 91 (5), pp. 486-491. [Online].